Language selection

Search

Patent 1052305 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1052305
(21) Application Number: 1052305
(54) English Title: INSOLUBILIZED PROTEINS ON POLYMERIC CONDENSATION PRODUCTS
(54) French Title: PROTEINES RENDUES INSOLUBLES PAR DES PRODUITS POLYMERIQUES DE CONDENSATION
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
Abstracts

English Abstract


ABSTRACT
This invention relates to a process for the fixing or insolu-
bilising of proteins, which process comprises bonding the protein to a
polymeric condensation product obtained by reacting a carbocyclic, aromatic
polyamine with an aliphatic dialdehyde or acrolein, other than the 1,3-
phenylenediamine glutardialdehyde condensation product.


Claims

Note: Claims are shown in the official language in which they were submitted.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the fixing or insolubilising of proteins, which
process comprises bonding the protein to a polymeric condensation product
obtained by reacting a carbocyclic, aromatic polyamine with an aliphatic
dialdehyde or acrolein, other than the 1,3-phenylenediamine glutardialdehyde
condensation product.
2. A process according to claim 1, wherein in the condensation product
a diamine is used as the carbooyclic, aromatic polyamine.
3. A process according to claim 1 or claim 2, wherein in the condensa-
tion product glutardialdehyde is used as the dialdehyde.
4. A process according to claim 1, wherein the condensation product is
obtained by reaction of benzidine with glutardialdehyde.
5. A process according to claim 1, wherein the condensation product is
obtained by reaction of 2,4,6-triaminotoluene with glutardialdehyde.
6. A process according to claim 1, wherein the condensation product is
obtained by reaction of 1 mole of polyamine with 1-10 moles of aldehyde.
7. A process according to claim 1, wherein the reaction to obtain the
condensation product is carried out in the presence of a fine-grained, solid,
inert adjuvant.
8. A process according to claim 7, wherein the adjuvant is a silicate
or a silicate-containing material.
9. A process according to claim 8, wherein silica gel is used as the
adjuvant.
11

10. A process according to claim 1, wherein the reaction to obtain the
condensation product is carried out in a two-phase system.
11. A process according to cliam 10, wherein the two-phase system con-
sists of an aqueous phase and a water-immiscible organic phase.
12. A process according to claim 11, wherein the water-immiscible organ-
ic phase is chloroform.
13. A process according to claim 1, wherein the condensation product is
diazotised.
14. A process according to claim 1 wherein the protein is an enzyme.
15. A process according to claim 14, wherein the bonding is carried out
by passing a solution of the protein through a column containing the conden-
sation product.
16. A protein bound to a condensation product and obtained according to
the process claimed in claim 1, 2 or 3.
17. A protein bound to a condensation product and obtained according to
the process claimed in claim 4, 5 or 6.
18. A protein bound to a condensation product and obtained according to
the process claimed in claim 7, 8 or 9.
19. A protein bound to a condensation product and obtained according to
the process claimed in claim 10, 11 or 12.
20. A protein bound to a condensation product and obtained according to
the process claimed in claim 13.
21. An enzyme bound to a condensation product and obtained according to
the process claimed in claim 1, 2 or 3.
12

22. An enzyme bound to a condensation product and obtained according to
the process claimed in claim 4, 5 or 6.
23. An enzyme bound to a condensation product and obtained according to
the process claimed in claim 7, 8 or 9.
24. An enzyme bound to a condensation product and obtained according to
the process claimed in claim 10, 11 or 12.
25. An enzyme bound to a condensation product and obtained according to
the process claimed in claim 13.
13

Description

Note: Descriptions are shown in the official language in which they were submitted.


ifA~3~
The present invention is concerned with the fixing or insolu-
bilising of proteins.
An object of the Canadian Patent Appllcation No. 192,733 is
the manufackure of the novel condensation product obtained by reacting
1,3-phenylenediamine with glutardialdehyde, which is distinguished by
having a large bonding capacity for proteins.
It has now been found in accordance with the present invention
that a series of further structurally related amines may be reacted
with the same or with structurally similar dialdehydes, or also with
acrolein, in the same manner to give condensation products which are
likewise suitable in an outstanding manner for the same purpose~j namely
for the fixing or insolubilising of proteins.
Accordingly, the present invention provides a process for the
fixing or insolubilising of proteins, which process comprises bonding
the protein to a polymeric condensation product obtained by reacting
a carbocyclic, aromatic polyamine with an aliphatic dialdehyde or acro-
~ lein, other than the 1,3-phenylenediamine glutardialdehyde condensation
; product.
The polyamine-aldehyde resins can be made reacting a carbocyclic
aromatic polymaine with an aliphatic dialdehyde or acrolein to give a
condensation product suitable for the fixing or insolubilising of proteins
,:

~s~s
~the manufacture of the 1,3-phenylenediamine glutardialdehyde condensation
product being excluded).
Carbocyclic, aromatic polyamines which can be used in the for-
mation of the condensation product include diamines or triamines, that is
mononuclear compounds such as phenylenediamines (e.g. p-phenylenediamine)
and phenylenetriamines ~e.g. 2,4,6-triaminophenol, 2,~,6-triaminotoluene),
polynuclear compounds such as biphenyldiamines (e.g. ben~idine) or poly-
nuclear compounds with aliphatic bridges, such as diaminodiphenylalkanes
~e.g. diaminodiphenylmethanes).
Apart from amino groups, the aromatic nuclei can also carry
other substituents such as halogen atoms ~e.g. chlorine), lower alkyl
groups ~e.g. methyl, ethyl), lower alkoxy groups ~e.g. methoxy, ethoxy)
or hydroxy, carboxy, mercapto, lower alkylthio or sulphonyl groups.
Finally, mixtures of different polyamines can also be employed
as reaction components in the manufacture of the condensation products
in accordance with the invention.
Preferred polyamine reaction components are banzidine and 2,4,
6-triaminotoluene.
~xamples of aliphatic dialdehydes which can be used in the for-
mation of the condensation product include glutardialdehyde, succinic acid
dialdehyde, glyoxal, etc. Glutardialdehyde is preferably used.
-- 3 --
. . , ~

~/~S'~3~5
~:`
~hether or not the condensation products manufactured
according to the process of the present invention are suitable
for the fixing or insolubilising of enzymes can be experimentally
determined in a simple manner by treating the condensation product
with an enzyme, preferably amyloglucosidase~ and measuring the
activity of the fixed ~nzyme. The suitabili~y is verified if
this activity comes to at least 50 to 100 units per gram of
; condensation product carrier material.
The following test procedure can be used for this purpose:
A chromatography column (1.5 x 15 cm~ is filled with 1 g
of the condensation product carrier materialO A solution of 1 g
of amyloglucosidase (50 units/mg) in 100 ml of 16 mmol acetate
buffer (pH 4.8) is passed through the column at rdom temperature
and with a flow rate of 20 ml per hour. As already mentioned,
; the fixe~ enzyme should have an activity of at least 50 to 100
units ~ of carrier material.
The activity is measured according to Zulkoski by way of
the glucose liberated from soluble starch. The liberated
glucose is determined enzymatically by means of the glucose-
oxidase/peroxidase test [Bergmeyer~ Methoden der enzymatischen
Analyse, Volume I, (19~0) page 41~]. [1 ~lit = that amoun~ of
enzyme which liberates 1 ~mol of glucose/min from soluble starch
at a reaction temperature of 60 C and at pH 4.8].
Alternatively, the suitability is verified if the
condensation product carrier material fixes at least 10 mg of a
protein (e.g. beef serum albumin) per gram of carrier. The
--'1--

~z~os
amount of fixed protein can be determined by hydrolysing the carrier-fixed
protein with 6-N hydrochloric acid and subsequently determining the amount of
free amino acids with the aid of any practicable analysis method for amino
acids.
Proteins which can be bonded to the condessation products in ac-
cordance with the present invention include polypeptides, antigens, anti-
bodies, protein inhibitors and~ especially~ enzymes~ The enzymes can be of
vegetahle, animal or microbial origin. The enzymes may be hydrolases
(peptidases, proteinases, desaminases, carbohydrases, esterases~ nucleases),
lyases or desmolases (hydrolyases, decarboxylases, aldolases), transferases,
iso~erases, oxidoreductases and ligases. Examples of enzymes from which
insoluble enzyme preparations provided by this invention can be n~nufactured
are alcoholdehydrogenase, naringinase, hesperidinase~-glucosidase, ~-amyl-
la~ invertase, amyloglucosidase, urease, trypsin, ficin, papain, bromelin,
subt;lopeptidase, rennin, glucoseisomerase, glucoseoxidase, peroxidase,
catalase, acylase, cytochrome, ribonuclease, phosphodiesterase and
adenyldeaminase.
According to ~Comprehensive Biochemistryl~ by Florkin ~. and Stotz
E. H. Volume 13, third edition, Elsevier Publishing Company, the enzymes have
the following enzyme numbers:
alcoholdehydrogenase 1 ol~
~-glucosidase 3.~.1.21
-amylase 3.2.1.2
invertase 3.2.1~26
amyloglucosidase 3.2.1.33
urease 3.5.1.5.
t~ypsin 3.4.4.4
ficin 3.4.4.12
papain 3.4~4.10
~, ', ' ! ~

~05'~3~5
bromelin 3.4.4.24
subtilopeptidase 3.4.4~16
rennin 3.4.4 3
glucoseisomerase 5.3~1 5
glucoseoxidase 1.1.3 4
peroxidase 1.11.l.7
catalase 1.11.1.6
acylase 3~1.1.6
cytochrome 1.9.3.1
ribonuclease 2.7.7.16
phosphodiesterase 3.1.4.1
adenyldeaminase 3.5.4.2
Naringinase and hesperidinase ha~e no numbers because they are
enzyme mixtures of ~-glucosidase and rhamnosidase~
The molar ratio of the polyamine and aldehyde reaction partners
expediently lies at between l:l and l:10, a ratiolof about 1:3 being pre-
ferred.
The reaction can be carried out in a manner known per se; for
example~ in aqueous solution, preferably with the addition of an acid such
2~ as a mineral acid (e.g. hydrochloric acid). In a particular embodiment,
the reaction is carried out in the presence of an inert, fine-grained,
preferably inorganic,
- 5a-

~5'~3~5
especially silicate-contain~g~ juuant.~ p~e~fo~-u~ch
adjuvants are silica gel, pumice-stone, diatomaceous earth
(kieselguhr)~ bentonite, wollastonite, porous glass and also
metal oxides such as aluminium oxide or hydroxylapatite. It
is preferred to use silica gel ~e.gO with a particle si7~e of
0.05-0.2 mm, 70-325 mesh) or pumice-stone (e.g. with a particle
siæe of 0.05-10 mm). The presence of such an adjuvant gives
rise to a homogeneous particle formation in the reaction andg
as a result~ an improved sedimentation is achieved. The
reaction in the presence of an adjuvant is expediently carr~d
out by initially bringing the particles into contact with one
of th~ two reaction compo~ènts and then adding the second
component with simultaneous or subsequent slight acidification.
The reaction can be carried out in a homogeneous phase or,
preferably~ in a two-phase system with the addition of an acid
such as a mineral acid ~e.g. sulphuric acid, phosphoric acid
or, preferably, hydrochlori~ acid) or an organic acid (e.g. a
carboxylic acid such as acetic acid) with vigorous stirring or
shaking. The use of a two-phase system promotes the formation
~0 of spherical~ substantially homogeneous particles which are
easy to filter and which sediment well, these particles being
especially well suited as a carrier materialO
Inert, water-immiscible organic solvents (e.g. di~hcloro-
methane, chloroform, carbon tetrachloride~ benzene~ toluene,
ethyl acetate~ dioxane, carbon disulphide3 are suitable as the
second phaseO Chlaroform is preferably used as the inertg
water-immiscible solvent, but acetone is also suitable for this
purpose.

~SZ3~
The reaction temperature is not critical, it can lie,
for example, at between 0C and 50C, preferably at room
temperature (i.eO at about 18-22 C.). In accordance with the
process provided by this invention there is obtained a conden-
sation product carrier material which, although already very
active, can be still further activated by diazotisation. The
diazotisation can be carried out in a manner known per se by
treatment with nitrite and acid.
In order to fix the protein to the carrier material, the
latter is treated with an aqueous s~-lution, preferably a
buffered solution~ of the protein (1-50 mg/ml) at a temperature
of 0 -30 C~ preferably 4 C to room temperature. This treatment
can be carried out while stirring or shaking. Because of the
high activity of the carrier material, the fixing of the proteins
can also be advantageously carried out by simply filtering the
protein solution through a carrier layer, preferably a column
filled with the carrier material~ as is common, for example,
; in column chromatography. Thus, for example, culture f~ltrates
of microorganisms which contain proteins or enzymes can be
allowed to run directly through a column of carrier material,
the proteins or enzymes being selectively fixed to the carrier.
The column is expediently rinsed with a buffer solution and
1-M potassium chloride solution in order to remove the non-fixed
proteins.
The proteins fixed to the carrier material are generally
very stable and very high specific activities (unit/g) are
achieved in the case of in enzymesD Loadings of, for example,
1:3-10 parts by weight of protein/carrier material are achieved.

3~
The carrier-bonded proteins provided by this inven~ion,
especially enzymes, can be used in a manner known per se; for
example, for analytical or preparative purposes or in food
technology such as in the manufacture of glucose from starch
~see3 or example., Scientific American 224~ (No. 3) 26-33
( 1971); Angew. Chemie 849 (8) 319-268 ( 1972); Chemiker
Zeitung 96, (11), 595-602 ~1972); ~ & EN, ~15.2.71), 86-87].
In this important large-scale process, amyloglucosidase
fixed to the condensation product provided by the present
invention can be utilised for the manufacture of glucose from
the "glucose syrup" (prehydrolysed starch). The condensation
products can then be transferred~ for example, onto columns
(fixed-bed process). A further application results in the
enzymatic degradation of lactose in milk products by means of
lactases (e.g. I'sweets" from whey).
The following Examples illustrate the present invenkion.
The quantitative data of the carrier material obtained or used
is given with respect to dry weight.
xample 1
To a solution or suspension of 5 g of the polyamine in
200 ml of chloroform, there are added portionwise with vigorous
s~irring, firstly 20 g of aldehyde (80 ml of a 25% solution ~
water) and, after a further 5 minutes, 20 ml of 7-N hydrochloric
acid. The reaction mixture solidifies. It is treated with
300 ml of water and shaken for 5 minutes until it again becomes
liquid. The polymeric particles are left to stand for 1 hour
with occasional stirring. After vacuum filtration of the
mixture over a Bùchner funnel, the polymeric part:icles are

30~i
washed with three 200 ml portions of acetone and then with
0.1-~ sodium hydroxide solution. The residual chloroform is
removed by washing with acetone. The thus obtained carrier
particles are spherical, homogeneous and capable of good
filtration; they are stored in water or in d~llute sodium
hydroxide. They can be employed for enzyme fixing~9 optionally
after diazotisation.
Example 2
A chromatography column (1.5 x 15 cm) is filled with 1 g
of carrier material and washed with the buffer solution used
in the following enzyme fixing. The buffered enzyme solution
(1-100 mg of protein per ml of buffer) is passed through the
column with a flow rate of 20 ml/hour.
The coupling capacity is exhausted ~eh protein can be
detected in the eluate, which can be detected, for exa~ple by
measurement of the absorption spectrum at 280 m,u. The non-
fixed enzyme is removed by washing the column with 1-M
potassium chloride and the buffer solution. There then follows
an activity determination of an aliquot of the enzyme-fixed
material with the respective substrate under given reaction
conditions. Then an aliquot of the enzyme solution is washsd
with waterg dried and the dried material determined analogously.
The number of units of enzyme activity/g of carrier material
can be determined in this manner.
The condensation products manufactured according to
Example 1 and their corresponding activities determined
according to Example 2 are compiled in the following Table:

~ ~5~3~5
_ ~ _ _ . .
~ O
h ~ ~ >
~ ' _ _ _ __ . _ _ ~ .
~9'~ '7
_10 -

Representative Drawing

Sorry, the representative drawing for patent document number 1052305 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC expired 2020-01-01
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: First IPC derived 2006-03-11
Inactive: Expired (old Act Patent) latest possible expiry date 1996-04-10
Grant by Issuance 1979-04-10

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
None
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1994-04-18 1 13
Drawings 1994-04-18 1 10
Claims 1994-04-18 3 78
Descriptions 1994-04-18 10 320